FDA: COVID Vaccine Could Be Given Before Tests End
Aug. 31, 2020 — Emergency use authorization or approval for a COVID-19 vaccine before Phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administration, according to the agency’s commissioner, Dr. Stephen Hahn. “It is up to the sponsor [vaccine developer] to apply for authorization or approval, and we make … Read more